Pancreatic Cancer Research

ResearcherGebze Technical UniversityActive in the last 2 years

Elif Damla Arısan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4844-6381; OpenAlex author ID A5028719443. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 6

  1. Pyrazole-Cyclotriphosphazene Hybrids: Synthesis, Structural Insights, and Cytotoxic Effects against Pancreatic Cancer Cells. Last author DOI 10.1021/acsomega.5c11955↗
  2. Chemopreventive Effects of Lycopene in miR-21 Knockout and Wild-Type Pancreatic Cancer Cells. Last author DOI 10.1155/sci5/8865270↗
  3. microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/ijms23031275↗
  4. Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transit… Last author DOI 10.55730/1300-0152.2630↗
  5. Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy. Co-author DOI 10.1016/j.tranon.2021.101090↗
  6. Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells. Co-author DOI 10.1002/jcb.29249↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Başak Dalbayrak · 2 shared papers, 2026 · strength 0.74
  2. Pinar Uysal Onganer · 3 shared papers, 2021–2026 · strength 0.70
  3. Pınar Obakan Yerlikaya · 3 shared papers, 2020–2026 · strength 0.65
  4. Ceylan Mutlu Balcı · 1 shared paper, 2026 · strength 0.39
  5. Maria Mortoglou · 2 shared papers, 2021–2022 · strength 0.35
  6. Özge Rencüzoğulları · 2 shared papers, 2020–2022 · strength 0.29
  7. Sigrun Lange · 1 shared paper, 2022 · strength 0.17
  8. Hemant Mahendrakumar Kocher · 1 shared paper, 2021 · strength 0.17
  9. Dilek Telci Temeltaş · 1 shared paper, 2020 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.